acquired
Stage
About
CombinatoRx, founded in 2002, was a biopharmaceutical company that developed synergistic combination pharmaceuticals by creating product candidates with novel mechanisms of action to address complex human diseases. The company merged with Neuromed in 2009.
Explore CombinatoRx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.